Form CORRESP - Correspondence:
SEC Accession No. 0001104659-22-075759
Filing Date
2022-06-29
Accepted
2022-06-29 15:21:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 15634
2 GRAPHIC tm2220033d1_correspimage001.jpg GRAPHIC 9179
  Complete submission text file 0001104659-22-075759.txt   29575
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)